mRNA levels of enzymes and receptors implicated in arachidonic acid metabolism in gliomas

Clinical Biochemistry

Volumn 43, Issue 10-11, 2010, Pages 827-835

  De Armas, Rafael ^a,b   Durand, Karine ^a   Guillaudeau, Angélique ^a   Weinbreck, Nicolas ^a   Robert, Sandrine ^a   Moreau, Jean Jacques ^a   Caire, François ^a   Acosta, Gisela ^b   Pebet, Matias ^b   Chaunavel, Alain ^a   Marin, Benoît ^a   Labrousse, François ^a   Denizot, Yves ^c  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b Hospital das Clinicas Montevideo   (Uruguay)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

Arachidonic acid metabolism; Astrocytomas; Cyclooxygenase; Gliomas; Lipoxygenase; MRNA expression; Oligodendrogliomas; Quantitative RT PCR

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; THROMBOXANE SYNTHASE; LIPOXYGENASE; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL HETEROGENEITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC CODE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARACHIDONIC ACID; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; GLIOMA; HUMANS; LIPOXYGENASE; MALE; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953693089     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.03.017     Document Type: Article

References (46)

1. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97-109.
2. Castelli M.G., Butti G., Chiabrando C., Cozzi E., Fanelli R., Gaetani P., et al. Arachidonic acid metabolic profiles in human meningiomas and gliomas. J Neurooncol 1987, 5:369-375.
3. Nathoo N., Barnett G.H., Golubic M. The eicosanoid cascade: possible role in gliomas and meningiomas. J Clin Pathol 2004, 57:6-13.
4. Dupuis F., Desplat V., Praloran V., Denizot Y. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediat Cell Signal 1997, 16:117-125.
5. Kuhn H., Walther M., Kuban R.J. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat 2002, 68-69:263-290.
6. Radmark O. Arachidonate 5-lipoxygenase. Prostaglandins Other Lipid Mediat 2002, 68-69:211-234.
7. Yoshimoto T., Takahashi Y. Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat 2002, 68-69:245-262.
8. Cipollone F., Cicolini G., Bucci M. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol Ther 2008, 118:161-180.
9. Tanioka T., Nakatani Y., Semmyo N., Murakami M., Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000, 275:32775-32782.
10. Tanikawa N., Ohmiya Y., Ohkubo, Hashimoto K., Kangawa K., Kojima M., et al. Identification and characterization of a novel type of membrane associated prostaglandin E synthase. Biochem Biophys Res Commun 2002, 291:884-889.
11. Norel X. Prostanoid receptors in the human vascular wall. Sci World J 2007, 7:1359-1374.
12. Bennett A. The production of prostanoids in human cancers, and their implications for tumor progression. Prog Lipid Res 1986, 25:539-542.
13. Bosetti F. Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. J Neurochem 2007, 102:577-586.
14. Pidgeon G.P., Lysaght J., Krishnamoorthy S., Reynolds J.V., O'Byrne K., Nie D., et al. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007, 26:503-524.
15. Deininger M.H., Meyermann R., Trautmann K., Morgalla M., Duffner F., Grote E.H., et al. Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res 2000, 885:111-116.
16. Joki T., Heese O., Nikas D.C., Bello L., Zhang J., Kraeft S.K., et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 2000, 60:4926-4931.
17. Perdiki M., Korkolopoulou P., Thymara I., Agrogiannis G., Piperi C., Boviatsis E., et al. Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. Mol Cell Biochem 2007, 295:75-83.
18. Hara A., Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004, 108:43-48.
19. Shono T., Tofilon P.J., Bruner J.M., Owolabi O., Lang F.F. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 2001, 61:4375-4381.
20. Onguru O., Gamsizkan M., Ulutin C., Gunhan O. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma. Neuropathology 2008, 28:29-34.
21. Buccoliero A.M., Caldarella A., Arganini L., Mennonna P., Gallina P., Taddei A., et al. Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance. Neuropathology 2004, 24:201-207.
22. Castilla E.A., Prayson R.A., Kanner A.A., Rybicki L.A., Tubbs R.R., Vogelbaum M.A., et al. Cyclooxygenase-2 in oligodendroglial neoplasms. Cancer 2003, 98:1465-1472.
23. Tuettenberg J., Friedel C., Vajkoczy P. Angiogenesis in malignant glioma-a target for antitumor therapy?. Crit Rev Oncol Hematol 2006, 59:181-193.
24. Pradono P., Tazawa R., Maemondo M., Tanaka M., Usui K., Saijo Y., et al. Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 2002, 62:63-66.
25. Kurzel F., Hagel C., Zapf S., Meissner H., Westphal M., Giese A. Cyclo-oxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells. Acta Neurochir 2002, 144:71-87. (Wien).
26. Giese A., Hagel C., Kim E.L., Zapf S., Djawaheri J., Berens M.E., et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro Oncol 1999, 1:3-13.
27. Kokoglu E., Tuter Y., Sandikci K.S., Yazici Z., Ulakoglu E.Z., Sonmez H., et al. Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors. Cancer Lett 1998, 132:17-21.
28. Mattila S., Tuominen H., Koivukangas J., Stenbäck F. The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas. Neuropathol 2009, 29:156-165.
29. Nakano Y., Kuroda E., Kito T., Yokota A., Yamashita U. Induction of macrophagic prostaglandin E2 synthesis by glioma cells. J Neurosurg 2006, 104:574-582.
30. Nathoo N, Prayson RA, Bondar J, et al.: Increased expression of 5-ipoxygenase in high-grade astrocytomas. Neurosurgery 2006; 58:347-54; discussion -54.
31. Boado R.J., Pardridge W.M., Vinters H.V., Black K.L. Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family. Proc Natl Acad Sci U S A 1992, 89:9044-9048.
32. Vincent J.E., Freidlin B. Targeting epidermal growth factor receptor-are we missing the mark?. Lancet 2003, 362:62-64.
33. Fiancette R., Amin R., Truffinet V., Vincent-Fabert C., Cogné N., Cogné M., et al. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies. Leuk Res 2009, 15. Electronic publication.
34. Denizot Y., Godard A., Raher S., Trimoreau F., Praloran V. Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells. Cytokine 1999, 11:606-610.
35. Denizot Y., Trimoreau F., Praloran V. Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells. Cytokine 1998, 10:781-785.
36. Redova M, Chlapek P, Loja T, et al.: Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines. International journal of molecular medicine; 25:271-80.
37. Moreno J.J. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol 2009, 77:1-10.
38. Deininger M.H., Weller M., Streffer J., Mittelbronn M., Meyermann R. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 1999, 98:240-244.
39. Jantke J., Ladehoff M., Kurzel F., Zapf S., Kim E., Giese A. Inhibition of the arachidonic acid metabolism blocks endothelial cell migration and induces apoptosis. Acta Neurochir 2004, 146:483-494. (Wien).
40. Fulton A. The role of eicosanoids in tumor metastasis. Prostaglandins Leukot Essent Fatty Acids 1988, 34:229-237.
41. Cooper C., Jones H.G., Weller R.O., Walker V. Production of prostaglandins and thromboxane by isolated cells from intracranial tumours. J Neurol Neurosurg Psychiatry 1984, 47:579-584.
42. Gaetani P, Rodriguez y Baena R, Marzatico F, Lombardi D, Knerich R, Paoletti P: "Ex vivo" release of eicosanoid from human brain tissue: its relevance in the development of brain edema. Neurosurgery 1991; 28:853-7; discussion 7-8.
43. 2 receptor-dependent signaling pathways. Faseb J 2001, 15:1517-1528.
44. Kim E., Gunther W., Yoshizato K., Meissner H., Zapf S., Nusing R.M., et al. Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1. Oncogene 2003, 22:7716-7727.
45. McDonough W., Tran N., Giese A., Norman S.A., Berens M.E. Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 1998, 57:449-455.
46. Yoshizato K., Zapf S., Westphal M., Berens M.E., Giese A. Thromboxane synthase inhibitors induce apoptosis in migration-arrested glioma cells. Neurosurgery 2002, 50:343-354.